Adynovate Prices, Coupons, Copay Cards & Patient Assistance
Adynovate (antihemophilic factor) is a member of the miscellaneous coagulation modifiers drug class and is commonly used for Hemophilia A.
Adynovate prices
Intravenous Powder For Injection
recombinant PEGylated Adynovate intravenous powder for injection from $12.74 for 1 powder for injection
| Quantity | Per unit | Price |
|---|---|---|
| 1 | $12.74 | $12.74 |
Important: When there is a range of pricing, consumers should normally expect to pay the lower price. However, due to stock shortages and other unknown variables we cannot provide any guarantee.
Get your FREE Drugs.com Discount Card
Save up to 80% off the cost of prescription drugs and OTC medicines valid at over 65,000 pharmacies.
This is a drug discount program, not an insurance plan.
Adynovate Coupons, Copay Cards and Rebates
Adynovate offers may take the form of printable coupons, rebates, savings or copay cards, trial offers, or free samples. Certain offers may be printable from a website while others may require registration, completing a questionnaire, or obtaining a sample from a medical professional.
Adynovate Takeda Patient Support Program
Eligible commercially insured patients may get up to 100% of their out-of-pocket co-pay costs covered, with savings up to $20,000 per year.
- Applies to:
- Adynovate
- Number of uses:
- Per prescription per year
Form more information phone: 888-229-8379 or Visit website
Adynovate Freedom of Choice Free Trial Program
Eligible NEW patients may receive 8 free doses of medication.
- Applies to:
- Adynovate
- Number of uses:
- One-time offer
Form more information phone: 888-229-8379 or Visit website
Patient Assistance & Copay Programs for Adynovate
Patient assistance programs (PAPs) are typically sponsored by pharmaceutical companies and offer cost-free or discounted medicines, as well as copay programs, to individuals with low income or those who are uninsured/under-insured and meet specific criteria. Eligibility requirements for each program may vary.
Provider: Patient Access Network Foundation (PAN)
Eligibility requirements:- *See Additional Information section below
- Between 400-500% of FPL
- FDA Approved Diagnosis - See Program Website for Details
- Must reside and receive treatment in US
- *Patients must have health insurance and their insurance must cover the qualifying medication for which they seek assistance. Call for most recent medications as the list is subject to change and the medication for which you are seeking assistance must treat the disease directly. Note: All new enrollment is now done electronically or over the phone. Contact program for details.
- Adynovate (antihemophilic factor recombinant pegylated) Injection; IV Lyophilized powder
More information please phone: 866-316-7263 Visit website
Provider: Takeda Patient Support
Eligibility requirements:- Determined case by case
- Based on FPL
- FDA-approved diagnosis
- Must be residing in the US or a US territory, and under the care of a US physician
- Co-payment assistance, patient support, and patient assistance programs are available for eligible patients.
- Adynovate (antihemophilic factor recombinant pegylated) Injection; IV Lyophilized powder
More information please phone: 877-825-3327 Visit website
Disclaimer: Medication pricing is sourced from a variety of providers. Pricing may vary significantly due to several factors including brand or generic status, insurance coverage, pharmacy choice, location, and manufacturer pricing policies. Prices are subject to change. For the most accurate and up-to-date information, always consult directly with your pharmacy or healthcare provider.
See also:
Lysteda
Lysteda (tranexamic acid) is used to treat heavy menstrual bleeding. Includes Lysteda side effects ...
DDAVP
DDAVP is used for diabetes insipidus, hemophilia a, primary nocturnal enuresis, von Willebrand Disease
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Qfitlia
Qfitlia is used for hemophilia a, hemophilia a with inhibitors, hemophilia b, hemophilia b with ...
Altuviiio
Altuviiio is a once-weekly recombinant fact VIII replacement therapy used by hemophilia A patients ...
Cyklokapron
Cyklokapron is used for bleeding disorder, factor ix deficiency, hemophilia a
Hemlibra
Hemlibra is a monoclonal antibody that functions in place of a natural blood-clotting factor that ...
Hympavzi
Hympavzi (marstacimab-hncq) may be used to prevent or reduce the frequency of bleeding episodes ...
More about Adynovate (antihemophilic factor)
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous coagulation modifiers
- Breastfeeding
- En español
Patient resources
Other brands
Altuviiio, Advate, Kovaltry, Xyntha, ... +14 more
Professional resources
- Adynovate prescribing information
- Antihemophilic Factor (recombinant), PEGylated-aucl (AHFS Monograph)
Other brands
Altuviiio, Advate, Kovaltry, Xyntha, ... +12 more